Healthcare - Biotechnology - NASDAQ - US
$ 7.03
-5.64 %
$ 1.46 B
Market Cap
-11.92
P/E
Price Target
Average
84.92%
Revenue Forecast
Estimate
24.88%
EBIT
Estimate
--54.56%
Net Income
Estimate
29.67%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
BioCryst Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for BCRX of $13 , with forecasts ranging from a low of $7 to a high of $25 .
BCRX Lowest Price Target
Wall Street Target
7 USD
-0.43%
BCRX Average Price Target
Wall Street Target
13 USD
84.92%
BCRX Highest Price Target
Wall Street Target
25 USD
255.62%
REVENUE FORECAST
Revenue Forecast Chart BCRX
EBIT FORECAST
EBIT Forecast Chart BCRX
NET INCOME FORECAST
Net Income Chart BCRX